Literature DB >> 8320750

Detection of choline-acetyltransferase activity in lymphocytes.

I Rinner1, K Schauenstein.   

Abstract

The cholinergic system takes part in the immune-neuroendocrine integration. Lymphocytes have been found to express muscarinic and nicotinic cholinergic receptors, as well as acetylcholine-esterase on their surface, and cholinergic agents modulate immune functions in vitro and in vivo. In the present study we provide evidence that purified organ resident and circulating lymphocytes, as well as various lymphoid cell lines derived from different species, exhibit choline-acetyltransferase activity and, therefore, have the potential to produce the neurotransmitter acetylcholine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8320750     DOI: 10.1002/jnr.490350209

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  11 in total

1.  Muscarinic Receptor M3R Signaling Prevents Efficient Remyelination by Human and Mouse Oligodendrocyte Progenitor Cells.

Authors:  R Ross Welliver; Jessie J Polanco; Richard A Seidman; Anjali K Sinha; Melanie A O'Bara; Zainab M Khaku; Diara A Santiago González; Akiko Nishiyama; Jurgen Wess; M Laura Feltri; Pablo M Paez; Fraser J Sim
Journal:  J Neurosci       Date:  2018-06-29       Impact factor: 6.167

2.  Cardiac acetylcholine inhibits ventricular remodeling and dysfunction under pathologic conditions.

Authors:  Ashbeel Roy; Mouhamed Dakroub; Geisa C S V Tezini; Yin Liu; Silvia Guatimosim; Qingping Feng; Helio C Salgado; Vania F Prado; Marco A M Prado; Robert Gros
Journal:  FASEB J       Date:  2015-10-19       Impact factor: 5.191

3.  Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit.

Authors:  Mauricio Rosas-Ballina; Peder S Olofsson; Mahendar Ochani; Sergio I Valdés-Ferrer; Yaakov A Levine; Colin Reardon; Michael W Tusche; Valentin A Pavlov; Ulf Andersson; Sangeeta Chavan; Tak W Mak; Kevin J Tracey
Journal:  Science       Date:  2011-09-15       Impact factor: 47.728

4.  Distribution of the vesicular acetylcholine transporter (VAChT) in the central and peripheral nervous systems of the rat.

Authors:  M K Schäfer; E Weihe; H Varoqui; L E Eiden; J D Erickson
Journal:  J Mol Neurosci       Date:  1994       Impact factor: 3.444

5.  Elevated O-GlcNAcylation enhances pro-inflammatory Th17 function by altering the intracellular lipid microenvironment.

Authors:  Miranda Machacek; Harmony Saunders; Zhen Zhang; Ee Phie Tan; Jibiao Li; Tiangang Li; Maria T Villar; Antonio Artigues; Todd Lydic; Gentry Cork; Chad Slawson; Patrick E Fields
Journal:  J Biol Chem       Date:  2019-04-22       Impact factor: 5.157

6.  In vivo and in vitro effects of pilocarpine: relevance to ictogenesis.

Authors:  Nicola Marchi; Emily Oby; Ayush Batra; Laura Uva; Marco De Curtis; Nadia Hernandez; Anette Van Boxel-Dezaire; Imad Najm; Damir Janigro
Journal:  Epilepsia       Date:  2007-07-20       Impact factor: 5.864

Review 7.  Cholinergic activity as a new target in diseases of the heart.

Authors:  Ashbeel Roy; Silvia Guatimosim; Vania F Prado; Robert Gros; Marco A M Prado
Journal:  Mol Med       Date:  2015-01-26       Impact factor: 6.354

8.  Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice.

Authors:  Eulalia de la Torre; Lilia Davel; María A Jasnis; Tomomi Gotoh; Eugenia Sacerdote de Lustig; María E Sales
Journal:  Breast Cancer Res       Date:  2005-03-04       Impact factor: 6.466

Review 9.  Expression and Function of the Cholinergic System in Immune Cells.

Authors:  Takeshi Fujii; Masato Mashimo; Yasuhiro Moriwaki; Hidemi Misawa; Shiro Ono; Kazuhide Horiguchi; Koichiro Kawashima
Journal:  Front Immunol       Date:  2017-09-06       Impact factor: 7.561

10.  Autonomic and Redox Imbalance Correlates With T-Lymphocyte Inflammation in a Model of Chronic Social Defeat Stress.

Authors:  Cassandra M Moshfegh; Safwan K Elkhatib; Christopher W Collins; Allison J Kohl; Adam J Case
Journal:  Front Behav Neurosci       Date:  2019-05-14       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.